Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16

References

• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327.
   PubMed Web of Science ®Google Scholar
• Holt KE, Wertheim H, Zadoks RN, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci USA. 2015;112(27):E3574–E3581.
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):252–275.
   PubMed Web of Science ®Google Scholar
• Lester CH, Olsen SS, Jakobsen L, et al. Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand. Int J Antimicrob Agents. 2011;38(2):180–182.
   PubMed Web of Science ®Google Scholar
• Boonyasiri A, Jauneikaite E, Brinkac LM, et al. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017. BMC Infect Dis. 2021;21(1):142.
   PubMed Web of Science ®Google Scholar
• Marcade G, Brisse S, Bialek S, et al. The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region. Epidemiol Infect. 2013;141(8):1705–1712.
   PubMed Web of Science ®Google Scholar
• Moradigaravand D, Martin V, Peacock SJ, et al. Evolution and Epidemiology of multidrug-resistant Klebsiella pneumoniae in the United Kingdom and Ireland. MBio. 2017;8(1):e01976–16.
   PubMed Web of Science ®Google Scholar
• Espinal P, Nucleo E, Caltagirone M, et al. Genomics of Klebsiella pneumoniae ST16 producing NDM-1, CTX-M-15, and OXA-232. Clin Microbiol Infect. 2019;25(3):385.e1–385.e5.
   PubMed Web of Science ®Google Scholar
• Andrey DO, Pereira Dantas P, Martins WMBS, et al. An Emerging clone, Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae sequence type 16, associated with high mortality rates in a CC258-endemic setting. Clin Infect Dis. 2020;71(7):e141–e150.
   PubMed Web of Science ®Google Scholar
• Roca I, Akova M, Baquero F, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015;6:22–29. Erratum in: New Microbes New Infect 2015. 8. 175.
   PubMedGoogle Scholar
• Salmond GP, Fineran PC. A century of the phage: past, present and future. Nat Rev Microbiol. 2015;13(12):777–786.
   PubMed Web of Science ®Google Scholar
• Martins WMBS, Toleman MA, Gales AC. Clinical utilization of bacteriophages: a new perspective to combat the antimicrobial resistance in Brazil. Braz J Infect Dis. 2020;24(3):239–246.
   PubMed Web of Science ®Google Scholar
• European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints and dosing of antibiotics. [cited 2021 May 10]. Available from: http://www.eucast.org/clinical_breakpoints/.
   Google Scholar
• Centers for Disease Control and Prevention. PulseNet standard protocol. [cited 2021 Feb 20]. Available at: https://www.cdc.gov/pulsenet/pdf/ecoli-shigella-salmonella-pfgeprotocol-508c.pdf.
   Google Scholar
• Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233–2239.
   PubMed Web of Science ®Google Scholar
• Martins WMBS, Cino J, Li M, et al. Lytic bacteriophages against mutidrug-resistant Klebsiella pneumoniae: development of an effective phage-based approach to combat multidrug resistance. Research Square. 2021. Sep 07; doi: 10.21203/rs.3.rs-850585/v1.
   Google Scholar
• Gu Liu C, Green SI, Min L, et al. Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. MBio. 2020;11(4):e01462–20.
   PubMed Web of Science ®Google Scholar
• Jeon J, Yong D. Two novel bacteriophages improve survival in Galleria mellonella infection and mouse acute pneumonia models infected with extensively drug-resistant Pseudomonas aeruginosa. Appl Environ Microbiol. 2019;85(9):e02900–18.
   PubMed Web of Science ®Google Scholar
• Wright RCT, Friman VP, Smith MCM, et al. Resistance evolution against phage combinations depends on the timing and order of exposure. mBio. 2019;10(5):e01652–19.
   PubMed Web of Science ®Google Scholar
• Fang Q, Feng Y, McNally A, et al. Characterization of phage resistance and phages capable of intestinal decolonization of carbapenem-resistant Klebsiella pneumoniae in mice. Commun Biol. 2022;5(1):48.
   PubMed Web of Science ®Google Scholar
• Kumar M, Sarma DK, Shubham S, et al. Futuristic non-antibiotic therapies to combat antibiotic resistance: A review. Front Microbiol. 2021;12:609459.
   PubMed Web of Science ®Google Scholar
• Zurabov F, Zhilenkov E. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation. Virol J. 2021;18(1):9.
   PubMed Web of Science ®Google Scholar
• Corbellino M, Kieffer N, Kutateladze M, et al. Eradication of a multidrug-resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy With a custom made, Lytic Bacteriophage preparation. Clin Infect Dis. 2020;70(9):1998–2001.
   PubMed Web of Science ®Google Scholar
• Manohar P, Tamhankar AJ, Lundborg CS, et al. Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, Klebsiella pneumoniae, and enterobacter species. Front Microbiol. 2019;10:574.
   PubMed Web of Science ®Google Scholar
• Martins W, Mathias J, Babenko D, et al. Engineering the human microbiome, A natural double-barreled approach towards solving both our current antibiotic resistance and sepsis problems. Am J Biomed Sci Res. 2020;11(3). AJBSR.MS.ID.001632.
   Google Scholar
• Jeon J, Park JH, Yong D. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia. BMC Microbiol. 2019;19(1):70.
   PubMed Web of Science ®Google Scholar
• Thiry D, Passet V, Danis-Wlodarczyk K, et al. New bacteriophages against emerging lineages ST23 and ST258 of Klebsiella pneumoniae and efficacy assessment in Galleria mellonella larvae. Viruses. 2019;11(5):411.
   PubMed Web of Science ®Google Scholar
• Jansen M, Wahida A, Latz S, et al. Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii. Sci Rep. 2018;8(1):14140.
   PubMed Web of Science ®Google Scholar
• Azeredo J, Sutherland IW. The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol. 2008;9(4):261–266.
   PubMed Web of Science ®Google Scholar
• Abedon ST. Ecology of anti-biofilm agents II: bacteriophage exploitation and biocontrol of biofilm bacteria. Pharmaceuticals (Basel). 2015;8(3):559–589.
   PubMedGoogle Scholar
• de Sanctis J, Teixeira L, van Duin D, et al. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections. Int J Infect Dis. 2014;25:73–78.
   PubMed Web of Science ®Google Scholar
• Nguyen TNT, Nguyen PLN, Le NTQ, et al. Emerging carbapenem-resistant Klebsiella pneumoniae sequence type 16 causing multiple outbreaks in a tertiary hospital in southern Vietnam. Microb Genom. 2021;7(3):mgen000519.
   PubMed Web of Science ®Google Scholar